Skip to content
Search

Latest Stories

RPS addresses Guild Council's concerns on Royal College proposal

RPS addresses Guild Council's concerns on Royal College proposal

The RPS intends to present the final proposal to establish a Royal College of Pharmacy for a vote in early 2025  

The Royal Pharmaceutical Society (RPS) has responded to the concerns raised by the Guild of Healthcare Pharmacists (GHP) about their proposals to become a Royal College.

On behalf of the Guild Council, Rob Connah, president of GHP, recently wrote an open letter to the RPS seeking clarity on the potential impacts of this transition on career progression, time commitments, and other relevant considerations.


In response to the Guild Council’s inquiries regarding credentialing, RPS chief executive Paul Bennett emphasised that the key purpose of credentialing is to “protect the public and the integrity of the pharmacy profession through assuring patient-focused pharmacists working at advancing levels of post-registration practice.”

“Defining and assuring post-registration professional standards is a fundamental activity for a royal college and thus fully aligned with our proposals for change,” he added.

The RPS highlighted the benefits that credentialing can provide both pharmacists and the system.

Paul explained: “For a pharmacist, credentialing can support a standard professional career structure that offers potential for advancement.

“Credentialing also engenders professional confidence and pride, increases professional cohesion and provides a mechanism by which the skills and capabilities of an individual are recognised.”

For the employer and wider system, he stressed that “credentialing provides an objective and validated assurance mechanism for employee capability within and across organisations which can inform fair and valid career progression and recruitment decisions, assure consistency across the system and improve workforce portability.”

Additionally, he noted that it provides a mechanism by which other health professionals and patients can recognise the level of practice of the pharmacy workforce.

The RPS indicated that for credentialing to be fully integrated into the profession, it needs to be integrated into job descriptions, job plans and career progression, while stating “We continue to drive for this through our advocacy work.”

The Guild Council have expressed concern that the current NHS ecosystem offers limited time for pharmacists to focus on professional development.

The RPS acknowledged that providing pharmacists with “the time, space and support to develop professional practice portfolios” is essential for integrating credentialing meaningfully in the profession.

In response to the Council’s query about how NHS leaders will be supported in advocating for additional time for pharmacists to complete their portfolios, the RPS mentioned their advocacy through the Protected Learning Time policy while recognising the need for more effective job planning.

Additionally, Paul noted that their intention to register as a charity will ensure appropriate external frameworks and scrutiny, helping them achieve their goal of advancing pharmacy science and practice with patient and public benefit as a priority.

The RPS is currently engaging with its members and the broader profession about its proposals to become a Royal College, which are being presented through a series of ‘roadshow’ events across Great Britain in October and November.

The RPS has also invited the Guild of Healthcare Pharmacists to discuss the proposed transition to Royal College status.

Paul said: “We look forward to constructive dialogue with the Guild Council over the coming months as we refine our proposals for change and prepare to set the final proposition before our membership for a vote in early 2025.”

All pharmacists and pharmaceutical scientists are also encouraged to attend the roadshow events and learn more about the proposed changes.

 

More For You

Professor Sir Stephen Powis at a press briefing

Professor Sir Stephen Powis, was appointed national medical director of NHS England in 2018

NHS

NHS England’s top doctor to step down following Amanda Pritchard’s resignation

Just a week after NHS England chief executive Amanda Pritchard announced her resignation, the organisation’s national medical director, Professor Sir Stephen Powis, has confirmed he will step down this summer after more than seven years in the role.

In a statement released on Thursday, Professor Powis revealed that he had informed Pritchard of his intention to leave in a letter back in January.

Keep ReadingShow less
PDA calls on GP practices to use funding boost to improve job security for pharmacists

Now, it is time to focus on the community pharmacy contract

gettyimages

PDA urges GP practices to ensure funding boost supports employed pharmacists

The Pharmacists' Defence Association (PDA) has called on GP practicesto ensure that all healthcare professionals they employ, including pharmacists, benefit from the 7.2% funding boost they received under a newly agreed contract.

GP employers are encouraged to improve “job security, pay and conditions” for employees with this increased funding.

Keep ReadingShow less
Fourth Shift: Investment in Innovative Medicines Crucial for NHS 10-Year Plan Success

Medicines should be viewed as an investment rather than a cost

gettyimages

ABPI wants to see a ‘fourth shift’ in NHS 10-Year Health Plan


The Association of the British Pharmaceutical Industry (ABPI) has called on the government to increase investment in innovative medicines and vaccines, describing it as a crucial “fourth shift” necessary to ensure the NHS is fit for the future.

Keep ReadingShow less
Asda pharmacy launches UK’s first adult earache service

Asda makes ear health more accessible for everyone

gettyimages

Asda pharmacy launches £25 adult earache service

British supermarket chain Asda has launched the “UK’s first” adult earache service, aiming to reduce the burden on NHS services by eliminating the need for a GP appointment.

Priced at £25, the service allows patients aged 18 and over to book same-day appointments with qualified Asda pharmacists at any of its 226 pharmacies in England.

Keep ReadingShow less
Dr Penelope Dash new chair of NHS England

Dr Penny Dash is currently the chair of the NHS North West London Integrated Care Board

parliamentlive

Dr Penelope Dash appointed as new chair of NHS England

Dr Penny Dash has been appointed as the next chair of NHS England following an open public appointment process.

She will succeed Richard Meddings, who is set to step down next month, and her four-year term begins on April 1, 2025.

Keep ReadingShow less